Preethi Raghavan is a credentialed retroviral disease pharmacist by the Ministry of Health Malaysia and has been running the Medication Therapy Adherence clinic for Retroviral Disease (RVD) for the past 11 years. She is extensively involved as a RVD Preceptor in training pharmacist and building clinical knowledge as well as skills in retroviral disease for the state and country. She also actively conducts teaching sessions for nurses and doctors in the country.
Preethi is dedicated to improving medication management especially among HIV-infected patients by her active involvement with the infectious disease team and in conducting various research.
Preethi graduated with her Bachelor of Pharmacy (Hons) from University Science Malaysia in 2008 and Masters in Pharmacy Practice in 2020. One of her notable research , Impact of Point-Of-Care Pharmacist Counselling in Late Refills of ART, a study following the early warning indicators of World Health Organization was presented in London at the International AIDSImpact Conference 2019 and now has been established has part of the clinic/outpatient pharmacy protocol of the National Referral Center for Infectious Disease in Malaysia. She was also a board member of the RVD Sub-Committee at Pharmacy Services, Ministry of Health from 2016 to 2023 as well as one of the authors for the latest Malaysian Consensus Guidelines on Antiretroviral Therapy 2022.
